Browsing Over 91 ePosters

Sort By Relevance
View

18P - Influence of local immunity on the prognosis of gastric cancer (ID 19)

2P - Lung immune prognostic index (LIPI) can identify the fast-progressor to immune checkpoints inhibitors (ICI) in microsatellite instability (MSI) or mismatch repair deficient (dMMR) tumours (ID 91)

3P - Association between inflammation index and nutritional status and the effectiveness of immunotherapy in NSCLC treatment (ID 92)

4P - IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+ T-cells (ID 93)

5P - Uncovering the evolution of glioblastoma proteome landscape from primary to the recurrent stage for development of novel diagnostic and predictive biomarkers (ID 94)

6P - Role of inflammatory cytokines in distant metastasis of non-small cell lung cancer (ID 95)

7P - Peripheral blood-based biomarkers of prognosis and treatment response in patients with non-small cell lung cancer treated with PD-1 inhibitors (ID 96)

8P - Immune cell subsets in peripheral blood are associated with primary resistance to immunotherapy as frontline treatment in NSCLC (ID 97)

9P - Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994) (ID 98)

10P - Genomic profiles of CD47 in breast tumours predict outcome and are associated with immune activation and enrichment of pro-tumoral macrophage markers (ID 99)

12P - The correlation between non-coding RNA and response rate to immune-checkpoint inhibitors (ID 100)

13P - PD-L1 prevalence in advanced urothelial carcinoma by demographic and clinical characteristics (ID 101)